Abstract
Cherenkov emission from human tissues during linac-delivered radiotherapy provides a detectable optical signal that shows the real-time dose delivery. The challenge of this modality is that the linac pulses producing Cherenkov light have short durations (2–4 μs) with low duty cycle (0.1%), and the signal reaches the camera with near single photon per pixel intensity. In this study, the ability to use an ultra-low noise (94%. Additional advantages include low susceptibility to stray x-ray radiation. This recent development of ultra-low noise qCMOS technology is a unique option for Cherenkov imaging, showing the ability to image signals well above the noise without need for image intensifiers or gain amplification.
Funding Information
  • National Institutes of Health (R01 EB023909)
  • University of Wisconsin Carbone Cancer Center (P30 CA014520)

This publication has 9 references indexed in Scilit: